Osteopore Limited logo

Osteopore Limited (OSX)

Market Open
CXA CXA
- Market Cap
- P/E Ratio
- Div Yield
737,924 Volume
0 Eps
Want to track OSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OSX is not paying dividends to its shareholders.
Osteopore Limited has completed 2 stock splits, with the recent split occurring on Mar 14, 2024.
The company's stock is traded on one exchange.

Osteopore Limited (OSX) FAQ

On which exchange is it traded?

Osteopore Limited is listed on CXA.

What is its stock symbol?

The ticker symbol is OSX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Osteopore Limited ever had a stock split?

Osteopore Limited had 2 splits and the recent split was on Mar 14, 2024.

Osteopore Limited Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Dr. Yujing Lim CEO
CXA Exchange
- ISIN
Australia Country
- Employees
- Last Dividend
14 Mar 2024 Last Split
- IPO Date

Overview

Osteopore Limited is a pioneering medical device company that specializes in the design, development, and marketing of bioresorbable implants for use in neurosurgical, orthopedic, and maxillofacial surgeries. The company stands out in the medical field for its innovative approach to bone regeneration, leveraging cutting-edge 3D printing technology and bioresorbable materials to create implants designed to support natural bone healing processes. Founded in 2003 and based in Singapore, Osteopore has extended its operations globally, including in Australia, marking its presence as an international player in biomedical engineering. In addition to its product offerings, Osteopore has also entered into strategic collaborations, such as with Livingstone Health Holding Limited, aimed at developing new applications and products that further the company's mission to enhance regenerative bone and tissue technologies.

Products and Services

  • Osteoplug
  • This bioresorbable implant is a revolutionary product designed by Osteopore for use in neurosurgery. Specifically, Osteoplug is employed to cover trephination burr holes, which are created in the skull during surgical procedures. The implant serves an essential function by promoting bone regrowth in the trephination sites, ultimately dissolving into the body, thus eliminating the need for a second surgery to remove the implant.

  • Osteomesh
  • Osteomesh is another bioresorbable implant produced by Osteopore, but its application is primarily in craniofacial surgery. This product is designed to repair various types of fractures, including those in the orbital floor, and to fill surgical defects. By providing a scaffold for bone regeneration, Osteomesh supports the body's natural healing processes, seamlessly integrating with the patient's bone structure over time and then safely resorbing into the body.

Contact Information

Address: 191 Street Georges Terrace
Phone: 61 2 8072 1400